Renin–Angiotensin–Aldosterone System and Immunomodulation: A State-of-the-Art Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renin–Angiotensin–Aldosterone System and Immunomodulation: A State-of-the-Art Review
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 7, Pages 1767
Publisher
MDPI AG
Online
2021-07-14
DOI
10.3390/cells10071767
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin II receptor type 1 blockade improves hyporesponsiveness to vasopressors in septic shock
- (2021) Daniel Fernandes et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis
- (2020) Yuxiu Xie et al. Aging-US
- Sympathetic Enhancement of Memory T Cell Homing and Hypertension Sensitization
- (2020) Liang Xiao et al. CIRCULATION RESEARCH
- The renin–angiotensin system blockers and survival in digestive system malignancies
- (2020) Qi Zhou et al. MEDICINE
- Association between Angiotensin-Converting Enzyme Inhibitors and Lung Cancer—A Nationwide, Population-Based, Propensity Score-Matched Cohort Study
- (2020) Shih-Yi Lin et al. Cancers
- The Network of Angiotensin Receptors in Breast Cancer
- (2020) Filippo Acconcia Cells
- Using genetics to understand the role of antihypertensive drugs modulating angiotensin‐converting enzyme in immune function and inflammation
- (2020) Jie V. Zhao et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Angiotensin Receptor Blockers Associated with Improved Breast Cancer Survival—A Nationwide Cohort Study from Finland
- (2020) Eerik E.E. Santala et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- ACE (Angiotensin-Converting Enzyme) Inhibitors/Angiotensin Receptor Blockers Are Associated With Lower Colorectal Cancer Risk
- (2020) Ka Shing Cheung et al. HYPERTENSION
- Targeting tumor-associated macrophages as an antitumor strategy
- (2020) Nan Cheng et al. BIOCHEMICAL PHARMACOLOGY
- Current use of vasopressors in septic shock
- (2019) Thomas W. L. Scheeren et al. Annals of Intensive Care
- RECONSIDERING VASOPRESSORS FOR CARDIOGENIC SHOCK Everything should be made as simple as possible, but not simpler
- (2019) Pierre Squara et al. CHEST
- T lymphocyte-based renin angiotensin system in obesity
- (2019) Mirella Coppo et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Recommended Reading from the University of Toronto Critical Care Fellows
- (2019) Yasin A Khan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Adaptive Immunity in Hypertension
- (2019) Tomasz P. Mikolajczyk et al. CURRENT HYPERTENSION REPORTS
- Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
- (2019) Maya Guglin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation
- (2019) Johannes J. Kovarik et al. Scientific Reports
- Risk of urothelial cancer death among people using antihypertensive drugs—a cohort study from Finland
- (2019) Eerik E. E. Santala et al. Scandinavian Journal of Urology
- Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial
- (2019) Kealy R. Ham et al. Annals of Intensive Care
- Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers
- (2019) Tsuyoshi Ozawa et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Counter-regulatory renin–angiotensin system in cardiovascular disease
- (2019) Maria Paz Ocaranza et al. Nature Reviews Cardiology
- Vasopressor therapy in critically ill patients with shock
- (2019) James A. Russell INTENSIVE CARE MEDICINE
- Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality After Sepsis
- (2019) Wan-Ting Hsu et al. HYPERTENSION
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as therapeutic options in the treatment of renal cancer: A meta-analysis
- (2019) Fereshteh Asgharzadeh et al. LIFE SCIENCES
- Angiotensin II Regulates Th1 T Cell Differentiation Through Angiotensin II Type 1 Receptor-PKA-Mediated Activation of Proteasome
- (2018) Xian-Yun Qin et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Renin–Angiotensin System Inhibitors to Mitigate Cancer Treatment–Related Adverse Events
- (2018) Matthias Pinter et al. CLINICAL CANCER RESEARCH
- Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II
- (2018) James A. Tumlin et al. CRITICAL CARE MEDICINE
- Sepsis-induced myocardial dysfunction
- (2018) Keith R. Walley Current Opinion in Critical Care
- Vasodilatory shock in the ICU and the role of angiotensin II
- (2018) Brett J. Wakefield et al. Current Opinion in Critical Care
- FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock
- (2018) Fortunato Senatore et al. American Journal of Cardiovascular Drugs
- Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
- (2018) Blánaid M Hicks et al. BMJ-British Medical Journal
- The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival
- (2017) Taejong Song et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
- (2017) Andrew Rhodes et al. INTENSIVE CARE MEDICINE
- Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
- (2017) Edith Pituskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients
- (2017) Johannes J. Kovarik et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation
- (2017) William F. Fearon et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Immunologic Effects of the Renin-Angiotensin System
- (2017) Steven D. Crowley et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Angiotensin II for the Treatment of Vasodilatory Shock
- (2017) Ashish Khanna et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vasodilators in Septic Shock Resuscitation
- (2017) Thiago Domingos Corrêa et al. SHOCK
- Angiotensin II in Refractory Septic Shock
- (2017) Elio Antonucci et al. SHOCK
- Antihypertensive drug use and breast cancer risk: a meta-analysis of observational studies
- (2017) Haibo Ni et al. Oncotarget
- Prevention of Trastuzumab and Anthracycline-induced Cardiotoxicity Using Angiotensin-converting Enzyme Inhibitors or β-blockers in Older Adults With Breast Cancer
- (2017) Saranrat Wittayanukorn et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats
- (2017) Chu-Lin Chou et al. PLoS One
- Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy
- (2016) Takashi Yoshida et al. ANNALS OF SURGICAL ONCOLOGY
- Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway
- (2016) Fangtian Fan et al. BIOMEDICINE & PHARMACOTHERAPY
- Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
- (2016) Zachary S. Morris et al. CANCER
- The Incidence and Risk of Biochemical Recurrence Following Radical Radiotherapy for Prostate Cancer in Men on Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs)
- (2016) Abduelmenem Alashkham et al. Clinical Genitourinary Cancer
- Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
- (2016) Geeta Gulati et al. EUROPEAN HEART JOURNAL
- Renin-angiotensin system blockade for the risk of cancer and death
- (2016) J. Shen et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the UK Clinical Practice Research Datalink
- (2016) Katrina Wilcox Hagberg et al. PHARMACOTHERAPY
- Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer?
- (2016) Yeqing Mao et al. Oncotarget
- ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling
- (2016) Jason E. Davis et al. Oncotarget
- Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial
- (2016) Greg A Knoll et al. Lancet Diabetes & Endocrinology
- Expression of renin–angiotensin system (RAS) components in endometrial cancer
- (2016) Sarah J Delforce et al. Endocrine Connections
- Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis
- (2016) Xi Cao et al. Scientific Reports
- Compound 21, a selective agonist of angiotensin AT2receptors, prevents endothelial inflammation and leukocyte adhesionin vitroandin vivo
- (2015) Amanda K Sampson et al. BRITISH JOURNAL OF PHARMACOLOGY
- Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis
- (2015) Yi-Ning Dai et al. CANCER CAUSES & CONTROL
- ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity
- (2015) Vaibhav B. Patel et al. DIABETES
- Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer
- (2015) Michael L. Blute et al. JOURNAL OF UROLOGY
- The role of RAAS blockade in kidney transplantation
- (2015) Robert D. Toto Nature Reviews Nephrology
- Involvement of substance P and the NK-1 receptor in human pathology
- (2014) Miguel Muñoz et al. AMINO ACIDS
- A century old renin–angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology
- (2014) Pitchai Balakumar et al. CELLULAR SIGNALLING
- Angiotensin II in Septic Shock
- (2014) Thiago D. Corrêa et al. CRITICAL CARE MEDICINE
- Inflammatory triggers of acute rejection of organ allografts
- (2014) Daniel N. Mori et al. IMMUNOLOGICAL REVIEWS
- Ang II-AT1R Increases Cell Migration Through PI3K/AKT and NF-κB Pathways in Breast Cancer
- (2014) Yanbin Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis
- (2014) Maria Paz Ocaranza et al. JOURNAL OF HYPERTENSION
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosis
- (2014) WEI ZHANG et al. Experimental and Therapeutic Medicine
- Angiotensin-(1–7) Protects From Experimental Acute Lung Injury
- (2013) Nadine Klein et al. CRITICAL CARE MEDICINE
- Oral Formulation of Angiotensin-(1–7) Improves Lipid Metabolism and Prevents High-Fat Diet–Induced Hepatic Steatosis and Inflammation in Mice
- (2013) John David Feltenberger et al. HYPERTENSION
- Oral Angiotensin-(1–7) prevented obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF-κB in rats fed with high-fat diet
- (2013) Sérgio Henrique Sousa Santos et al. PEPTIDES
- Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
- (2013) Vikash P. Chauhan et al. Nature Communications
- Angiotensin-(1–7): beyond the cardio-renal actions
- (2012) Danielle G. Passos-Silva et al. CLINICAL SCIENCE
- Stress-dependent hypertension and the role of T lymphocytes
- (2012) Paul J. Marvar et al. EXPERIMENTAL PHYSIOLOGY
- Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion
- (2012) Clive N. May et al. INTENSIVE CARE MEDICINE
- Increased circulating angiotensin-(1–7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet
- (2012) Sérgio Henrique S. Santos et al. REGULATORY PEPTIDES
- Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes
- (2011) Chang Liu et al. ACTA DIABETOLOGICA
- Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies
- (2011) C. Yoon et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Intratubular Renin-Angiotensin System in Hypertension
- (2011) L. Gabriel Navar et al. HYPERTENSION
- The carboxypeptidase ACE shapes the MHC class I peptide repertoire
- (2011) Xiao Z Shen et al. NATURE IMMUNOLOGY
- Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: A randomized control trial
- (2011) Hitoshi Yoshiji ONCOLOGY REPORTS
- The innate immune system in transplantation
- (2011) Martin H. Oberbarnscheidt et al. SEMINARS IN IMMUNOLOGY
- Improved Lipid and Glucose Metabolism in Transgenic Rats With Increased Circulating Angiotensin-(1-7)
- (2010) Sérgio Henrique S. Santos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse
- (2010) Merlin C. Thomas et al. CIRCULATION RESEARCH
- Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality*
- (2010) John H. Boyd et al. CRITICAL CARE MEDICINE
- Angiotensin I-Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice
- (2010) S. M. Bindom et al. DIABETES
- Anti-Inflammatory Effects of the Activation of the Angiotensin-(1-7) Receptor, Mas, in Experimental Models of Arthritis
- (2010) K. D. da Silveira et al. JOURNAL OF IMMUNOLOGY
- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
- (2010) Ilke Sipahi et al. LANCET ONCOLOGY
- Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas
- (2010) Marina C. Muñoz et al. REGULATORY PEPTIDES
- Modulation of the renin–angiotensin–aldosterone system in sepsis: a new therapeutic approach?
- (2009) Diamantino Ribeiro Salgado et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice
- (2009) Christoph H. Österreicher et al. HEPATOLOGY
- Local angiotensin II-generation in human gastric cancer: Correlation with tumor progression through the activation of ERK1/2, NF-κB and survivin
- (2009) Kinoshita INTERNATIONAL JOURNAL OF ONCOLOGY
- Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
- (2009) Stefan Wilop et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus
- (2009) Atsuhito Saiki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET
- (2009) T. Philipp et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats
- (2009) May Al-Maghrebi et al. PHARMACOLOGICAL RESEARCH
- Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor
- (2009) Sudeep K. Bose et al. PROSTATE
- Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells
- (2008) E. T. Zambidis et al. BLOOD
- Cytosolic renin is targeted to mitochondria and inducesapoptosis in H9c2 rat cardiomyoblasts
- (2008) Heike Wanka et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats
- (2008) Yongzhong Wei et al. JOURNAL OF HEPATOLOGY
- Association of ACE Inhibitors and Angiotensin Receptor Blockers with Keratinocyte Cancer Prevention in the Randomized VATTC Trial
- (2008) J. B. Christian et al. JNCI-Journal of the National Cancer Institute
- Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer
- (2008) Gunnar Ronquist et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation